cycloastragenol has been researched along with Cardiac Failure in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cai, H; Cao, SP; Song, YH; Wang, J; Wu, ML; Zhao, ZM | 1 |
1 other study(ies) available for cycloastragenol and Cardiac Failure
Article | Year |
---|---|
Cycloastragenol ameliorates experimental heart damage in rats by promoting myocardial autophagy via inhibition of AKT1-RPS6KB1 signaling.
Topics: Animals; Astragalus propinquus; Autophagy; Cardiotonic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Drugs, Chinese Herbal; Heart Failure; Isoproterenol; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardium; Myocytes, Cardiac; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6 Kinases, 70-kDa; Sapogenins; Signal Transduction | 2018 |